Electrochemotherapy in the treatment of cutaneous metastases from breast cancer: a multicenter cohort analysis

Autor: A Santoriello, M Renne, Carlo Cabula, Roberto Agresti, Pietro Curatolo, Massimiliano D’Aiuto, Antonio Bonadies, Riccardo Bussone, Sara Valpione, Michele Guida, Nicola Solari, Luca Giovanni Campana, Gretha Grilz, M De Laurentiis, Sara Galuppo, L De Meo, Tommaso Fabrizio
Přispěvatelé: Cabula, C, Campana, L. G, Grilz, G, Galuppo, S, Bussone, R, De Meo, L, Bonadies, A, Curatolo, P, DE LAURENTIIS, Michelino, Renne, M, Valpione, S, Fabrizio, T, Solari, N, Guida, M, Santoriello, A, D'Aiuto, M, Agresti, R.
Rok vydání: 2017
Předmět:
Oncology
Electrochemotherapy
Skin Neoplasms
Receptor
ErbB-2

Cohort Studies
chemistry.chemical_compound
Surgical oncology
Antineoplastic Combined Chemotherapy Protocols
bleomycin
Carcinoma
Ductal
Breast

Follow up studies
Electrochemotherapy
Cutaneous Metastases
Breast Cancer

Hematology
Middle Aged
Prognosis
Receptors
Estrogen

Female
Receptors
Progesterone

Breast Neoplasm
Human
Cohort study
medicine.medical_specialty
Prognosi
Breast Neoplasms
Breast Oncology
Bleomycin
behavioral disciplines and activities
Follow-Up Studie
breast cancer
Breast cancer
Internal medicine
mental disorders
Biomarkers
Tumor

Carcinoma
medicine
Humans
Neoplasm Invasiveness
electrochemotherapy
breast cancer
chest wall recurrence
bleomycin

Aged
Neoplasm Staging
Neoplasm Invasivene
Antineoplastic Combined Chemotherapy Protocol
business.industry
chest wall recurrence
medicine.disease
chemistry
Progesterone metabolism
Surgery
Cohort Studie
business
Follow-Up Studies
Zdroj: Annals of Surgical Oncology
ISSN: 0923-7534
Popis: Background The management of breast cancer (BC) skin metastases represents a therapeutic challenge. Electrochemotherapy (ECT) combines the administration of bleomycin with temporary permeabilization induced by locally administered electric pulses. Preliminary experience with ECT in BC patients is encouraging. Methods A total of 125 patients with BC skin metastases who underwent ECT between 2010 and 2013 were enrolled onto a multicenter retrospective cohort study. The treatment was administered following the European Standard Operative Procedures of Electrochemotherapy. Tumor response was clinically assessed adapting the Response Evaluation Criteria in Solid Tumors, and toxicity was evaluated according to Common Terminology Criteria for Adverse Events 4.0. Cox regression analysis was used to identify predictive factors. Results Response was evaluable in 113 patients for 214 tumors (median 1 per patient, range 1–3). The overall response rate after 2 months was 90.2 %, while the complete response (CR) rate was 58.4 %. In multivariate analysis, small tumor size (P
Databáze: OpenAIRE